Enzene Biosciences Ltd | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Email & Communication
Keywords & Focus Areas
Enzene Biosciences Ltd
Overview
Enzene Biosciences Ltd is a global contract development and manufacturing organization (CDMO) and biosimilars developer based in Pune, India. Founded in 2015, the company specializes in biologics and biosimilars, aiming to provide trusted and affordable medicines that enhance global healthcare. With expanded operations that include facilities in the US, the company also maintains a strong focus on the European market.
It offers a range of fully integrated CDMO solutions, including research and development, analytics and testing, and GMP manufacturing. The firm supports the entire biologics journey, from discovery to commercialization, leveraging its patented EnzeneXβ’ continuous bioprocess platform for efficient and cost-effective production. A strong emphasis on quality and innovation has led to the successful commercialization of seven biosimilars in under three years, with continuous progress in biologics innovation.
Basic Information
| Industry | Biotechnology |
|---|---|
| Founded | 2015 |
| Revenue | 43M |
| Headquarters | Plot Number 165/1/26, Opp Hotel Fern Residency, MIDC, Bhosari, Pune, Maharashtra 411026, India |
Contact Details
- Phone: +91 213 561 4311
- Website: enzene.com
- LinkedIn: linkedin.com/company/enzene
Key Focus Areas & Initiatives
- Manufacturing
- Biologics
- Biosimilars
- Discovery
- Development
- Biopharmaceutical development
- Monoclonal antibodies
- Biosimilar manufacturing platform
- Biosimilar product pipeline
- Biosimilar scale-up
- Biosimilar process optimization
- Biosimilar analytical methods
- Biosimilar licensing
- Biosimilar commercialization
- Services
- Biosimilar quality control
- Biosimilar innovation
- Biologics manufacturing
- Continuous manufacturing platform
- Biosimilar pipeline development
- Biosimilar licensing packages
- Biosimilar clinical development
- Biosimilar manufacturing excellence
- Biosimilar pipeline
- Continuous bioprocessing
- Biologics process development
- Biologics stability testing
- Research and development in the physical, engineering, and life sciences
- Biosimilar cost efficiency
- GMP manufacturing
- Innovation
- Biosimilar development
- B2B
- Biosimilar product characterization
- Biosimilar process validation
- Biologics process optimization
- Biosimilar regulatory compliance
- Biosimilar validation
- Biosimilar cost reduction
- Pharmaceutical manufacturing
- Biologics validation services
- Biosimilar pipeline management
- Biosimilar global reach
- Perfused biomanufacturing
- Biologics R&D
- Biotech innovation
- Biosimilar market access
- GMP facilities
- Biosimilar clinical development services
- Biosimilar clinical trials
- Biopharmaceutical manufacturing
- Biosimilar process development
- Biosimilar quality assurance
- Biosimilar market expansion
- Biosimilar analytical development
- Biologics regulatory strategy
- Biologics scale-up
- Biosimilar manufacturing technology
- Biosimilar validation services
- Biosimilar product launch support
- Biosimilar technology
- Biosimilar product approval
- Biosimilar global markets
- Biopharmaceutical R&D
- Biosimilar regulatory strategy
- Biosimilar supply chain
- Biosimilar regulatory affairs
- Biosimilar stability testing
- CDMO
- Biosimilar product launch
- Biologics manufacturing facilities
- Cost-effective biologics production
- Biologics analytical development
- Biotechnology
- Contract research organization
- Biosimilar stability studies
- Biosimilar partnership
- Biosimilar regulatory support
- Drug development
- Cell line engineering
- Upstream process development
- Downstream process development
- Formulation development
- Drug substance manufacturing
- Continuous bioprocess manufacturing
- EnzeneX
- Method development
- Method validation
- Quality assurance
- Regulatory affairs
- Therapeutic proteins
- Recombinant enzymes
- AAV technology
- Bioassays
- Product characterization
- Stability studies
- Scale-up
- Lyophilization
- Phytopharmaceuticals
- Synthetic peptides
- Bispecific antibodies
- Fusion proteins
- Analytical solutions
- Dynamic process screening
- Clinical trial support
- Tech transfer
- GMP compliance
- Affordable medicines
- Drug product manufacturing
- Filling and finishing
- Global healthcare
- Quality management
- Clinical-scale manufacturing
- Pharmaceutical innovation
- Sustainable manufacturing
- Efficient resources utilization
- Local manufacturing capabilities
- Cost-effective solutions
- Biopharmaceuticals
- Therapeutic modalities
- Biologic pricing
- Product pipeline
- Biosimilarity packaging
- Manufacturing efficiency
- Healthcare
- Mechanical or industrial engineering
- Pharmaceuticals
- Medical
- Health care
- Health, wellness & fitness
- Hospital & health care
Technologies Used
- AWS Application Load Balancer
- Abnormal Security
- AdPilot
- Akamai CDN Solutions
- Bing Ads
- Blue Coat ProxySG
- CAT
- CLEAR
- Cedexis
- Cincopa
- Cisco VPN
- Cloudflare DNS
- Crowd Science
- Elite Software HVAC Solution
- Flow
- Fortinet
- Gem
- Google Tag Manager
- Greenhouse.io
- HPLC
- IBM Rational Software Architect Designer
- ICP
- IQMS
- ISO+β’
- Infoblox DHCP
- Ipswitch WhatsUp Gold
- JMP
- John Doe
- LabWare LIMS
- Microsoft Active Directory Federation Services
- Microsoft Advanced Group Policy Management
- Microsoft Hyper-V Server
- Microsoft Office 365
- Microsoft Windows Server 2012
- Microsoft-IIS
- Mobile Friendly
- NUnit
- Ning
- OSIsoft PI
- Olo
- Outlook
- PHP
- RSA SecurID Suite
- React
- Resi
- SAP
- SES
- Slack
- Thermo Scientific Chromeleon Chromatography Data System (CDS)
- Typekit
- VMware ESXi
- VMware vCenter Server
- Verizon WAF
- WordPress.org
- poly
- reCAPTCHA
- x:akta